Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 19Terminated 9Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Other neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Leukemia 8Myelodysplastic Syndromes 6Lymphoma 6Recurrence 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Congenital Abnormalities 4Neoplasms, Plasma Cell 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Leukemia, Myeloid, Accelerated Phase 3Hodgkin Disease 3Dendritic Cell Sarcoma, Interdigitating 3Burkitt Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Immunoblastic Lymphadenopathy 2Graft vs Host Disease 2Blast Crisis 2

Interventions

Cyclosporine 5Cyclophosphamide 5Busulfan 4fludarabine phosphate 3fludarabine 3Mycophenolic Acid 3thymoglobulin 2Methotrexate 2Drug Therapy 2Antilymphocyte Serum 2venetoclax 1trihexyltetradecylphosphonium chloride 1treosulfan 1tocilizumab 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Sirolimus 1Semustine 1Rituximab 1Radiotherapy 1Polymerase Chain Reaction 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Maraviroc 1Interferon alpha-2 1Immunoenzyme Techniques 1Decitabine 1Cytarabine 1Cyclosporins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Graft vs Host Disease × Antilymphocyte Serum × Clear all
NCT00093587 2013-11-06

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase NA Unknown
Other hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Leukemia

NCT00740467 2010-01-28

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

National Cancer Institute (NCI)

Phase 2 Unknown
50 enrolled
DermatologicLymphoidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Precancerous Conditions, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡